{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:38:23Z","timestamp":1790141903052,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1194,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1111\/j.1365-2133.2012.10878.x","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T20:03:56Z","timestamp":1328558636000},"page":"1342-1348","source":"Crossref","is-referenced-by-count":62,"title":["High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study"],"prefix":"10.1093","volume":"166","author":[{"given":"E.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"M\u00f8rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Skogvoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,25]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0190-9622(08)81509-5","article-title":"Nonmelanoma skin cancer in the United States: incidence","volume":"30","author":"Miller","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2012.10878.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/modpathol.3800512","article-title":"Basal cell carcinoma: biology, morphology and clinical implications","volume":"19","author":"Crowson","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB3|cit3","first-page":"CD003412","article-title":"Interventions for basal cell carcinoma of the skin","volume":"1","author":"Bath-Hextall","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2006.09.008","article-title":"Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma","volume":"25","author":"Szeimies","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","article-title":"Guidelines for topical photodynamic therapy: update","volume":"159","author":"Morton","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O","article-title":"5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges","volume":"79","author":"Peng","year":"1997","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience","volume":"6","author":"Kennedy","year":"1990","journal-title":"J Photochem Photobiol B"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005","volume":"56","author":"Braathen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB10|cit10","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5\u2003year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pdpdt.2009.09.001","article-title":"Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer","volume":"6","author":"Souza","year":"2009","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000183753","article-title":"Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy","volume":"218","author":"Gerritsen","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB13|cit13","first-page":"1170","article-title":"Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo","volume":"159","author":"Sandberg","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB14|cit14","volume-title":"Curettage and Topical ALA-based Photodynamic Therapy for Nodular Basal Cell Carcinoma","author":"Warloe","year":"1995"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1468-3083.2008.02946.x","article-title":"Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up","volume":"23","author":"Christensen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-4725.1989.tb03249.x","article-title":"Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB18|cit18","first-page":"677","article-title":"Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe","volume":"18","author":"Gollnick","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1524-4725.1991.tb03424.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 1: overview","volume":"17","author":"Silverman","year":"1991","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB20|cit20","volume-title":"The R Project for Statistical Computing","author":"R Development Core Team","year":"2010"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archderm.135.10.1177","article-title":"A systematic review of treatment modalities for primary basal cell carcinomas","volume":"135","author":"Thissen","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2010.03877.x","article-title":"Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response","volume":"25","author":"Fantini","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB23|cit23","first-page":"122","article-title":"The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma","volume":"9","author":"Farhadi","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(02)00516-5","article-title":"Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system","volume":"189","author":"Ramachandran","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1524-4725.2002.02902.x","article-title":"A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer","volume":"28","author":"Batra","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1524-4725.2001.27401.x","article-title":"Factors influencing the linear depth of invasion of primary basal cell carcinoma","volume":"27","author":"Takenouchi","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1524-4725.1981.tb00171.x","article-title":"Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score","volume":"7","author":"Rigel","year":"1981","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0167-8140(88)90052-7","article-title":"Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europ\u00e9en de Curietherapie","volume":"13","author":"Mazeron","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2133.2005.06484.x","article-title":"Photodynamic therapy with topical methyl aminolaevulinate for \u2018difficult-to-treat\u2019 basal cell carcinoma","volume":"152","author":"Vinciullo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial","volume":"159","author":"Mosterd","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1011-1344(01)00173-7","article-title":"Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate","volume":"62","author":"Peng","year":"2001","journal-title":"J Photochem Photobiol, B"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/1011-1344(95)07117-K","article-title":"Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice","volume":"28","author":"Malik","year":"1995","journal-title":"J Photochem Photobiol B"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1117\/12.203454","article-title":"Photodynamic therapy with 5-aminolevulinic acid-induced porphyrins and DMSO\/EDTA for basal cell carcinoma","volume":"2371","author":"Warloe","year":"1994","journal-title":"Proc SPIE"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"476362","DOI":"10.1155\/2011\/476362","article-title":"Basal cell carcinoma: 10\u2003years of experience","volume":"2011","author":"Cigna","year":"2011","journal-title":"J Skin Cancer"},{"key":"10.1111\/j.1365-2133.2012.10878.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-3083.2009.03430.x","article-title":"Guidelines for practical use of MAL-PDT in non-melanoma skin cancer","volume":"24","author":"Christensen","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.10878.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.10878.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:55:05Z","timestamp":1676382905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/166\/6\/1342\/6613865"}},"subtitle":["Prospective 10-year follow-up study of PDT in BCC"],"short-title":[],"issued":{"date-parts":[[2012,5,25]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10878.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,25]]}}}